SCHEMBL6888269

SCHEMBL6888269

COc1ncnc2nc([C@@H]3O[C@H](COC(C)=O)[C@H](OS(=O)(=O)c4ccc(C)cc4)[C@H]3OC(C)=O)[nH]c12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.38
▸ CA1 P00915 11/20 0.37
▸ CA2 P00918 11/20 0.37
▸ CA12 O43570 10/20 0.37
▸ CA4 P22748 6/20 0.37
▸ CA5A P35218 6/20 0.37
▸ CA7 P43166 6/20 0.37
▸ CA5B Q9Y2D0 6/20 0.37
▸ CYP2D6 P10635 1/20 0.36
▸ PTPN1 P18031 1/20 0.34
▸ CA9 Q16790 5/20 0.34
▸ ALDH1A1 P00352 4/20 0.34
▸ KDM4E B2RXH2 3/20 0.34
▸ MAPT P10636 3/20 0.34
▸ HPGD P15428 3/20 0.34
▸ LMNA P02545 2/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ PTGS2 P35354 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6886416 0.91 TSHR (0.39) TSHRCA1CA2CA12CA4
SCHEMBL6885027 0.89 TSHR (0.38) TSHRCA1CA2CA12CA4
SCHEMBL6885580 0.87 TSHR (0.47) TSHRCA1CA2CA12CA4
SCHEMBL6880949 0.87 TSHR (0.36) TSHRCA1CA2CA12CA4
SCHEMBL6882311 0.83 LMNA (0.42) TSHRCA1CA2CA12CA4
SCHEMBL6887860 0.80 TSHR (0.37) TSHRCA1CA2CA12CA4
SCHEMBL6888266 0.77 TSHR (0.40) TSHRCA1CA2CA12CA4
SCHEMBL6887838 0.76 TSHR (0.49) TSHRCA1CA2CA12CA4
SCHEMBL6885775 0.74 TSHR (0.47) TSHRCA1CA2CA12CA4
SCHEMBL3702924 0.73 CA2 (0.53) CA1CA2CA12CA4CA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1411954-A2 MODIFIED NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS AND ABNORMAL CELLULAR PROLIFERATION Pharmasset Limited (BB) 2004-04-28 — — EP disclosed
WO-2002032920-A2 MODIFIED NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS AND ABNORMAL CELLULAR PROLIFERATION PHARMASSET LIMITED (BB) 2002-04-25 — — WO disclosed
Send feedback